Abrigana, Pacensia B.

HRN: 23 25 99  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/26/2025
CEFTAZIDIME 1GM (VIAL)
09/26/2025
10/02/2025
IV
1gm
Q8
Cap
Checking Initial Appropriateness 

 Indication:  Empiric    Type of Infection:  Pneumonia    Compliance to guidelines: Compliant To Guidelines